You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 3
  • 180 An open-label randomized active-controlled phase ii clinical study to assess efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer

Citation Tools

Article menu

Download PDFPDF

Poster
IGCS20_1171
180 An open-label randomized active-controlled phase ii clinical study to assess efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Yue Y, Shen H, Lu C, et al
180 An open-label randomized active-controlled phase ii clinical study to assess efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer
International Journal of Gynecologic Cancer 2020;30:A78.